Search This Blog

Thursday, October 31, 2019

NovoCure EPS beats by $0.06, beats on revenue

NovoCure (NASDAQ:NVCR): Q3 GAAP EPS of $0.02 beats by $0.06.
Revenue of $92.1M (+42.1% Y/Y) beats by $4.98M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)